Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2016

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. USO
2. META
3. SPY
4. MSFT
5. MU
6. COST
7. IONS
8. SKHY
9. ORCL
10. RMR

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2016

Enanta Pharma (ENTA) Misses Q2 EPS by 5c

August 8, 2016 5:07 PM EDT

Enanta Pharma (NASDAQ: ENTA) reported Q2 EPS of ($0.06), $0.05 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $14 million versus the consensus estimate of $13.05 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

... More